Cover Image
Market Research Report

Global Malignant Mesothelioma Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 765568
Published Content info 101 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Malignant Mesothelioma Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 101 Pages
Description

Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium).

Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the forecast period, owing to the increasing direct procurement of mesothelioma drugs by governments to ensure availability in hospital pharmacies and oncology centers.

In 2018, the global Malignant Mesothelioma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Malignant Mesothelioma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Mesothelioma development in United States, Europe and China.

The key players covered in this study

  • AstraZeneca
  • Bristol-Myers Squibb
  • Roche
  • Merck
  • Novartis
  • Pfizer
  • Sanofi
  • Eli Lilly
  • Teva Pharmaceuticals
  • Boehringer Ingelheim GmbH
  • Mylan
  • Fresenius Kabi
  • Sun Pharmaceuticals
  • Corden Pharma
  • Concordia International
  • Kyowa Hakko Kirin
  • Polaris Pharmaceuticals
  • MolMed
  • Ono Pharmaceutical
  • Nichi-Iko Pharmaceutical

Market segment by Type, the product can be split into

  • Oral
  • Parenteral

Market segment by Application, split into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Oncology Centers
  • Other

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Malignant Mesothelioma status, future forecast, growth opportunity, key market and key players.
  • To present the Malignant Mesothelioma development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Malignant Mesothelioma are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Malignant Mesothelioma Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Oral
    • 1.4.3 Parenteral
  • 1.5 Market by Application
    • 1.5.1 Global Malignant Mesothelioma Market Share by Application (2014-2025)
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Oncology Centers
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Malignant Mesothelioma Market Size
  • 2.2 Malignant Mesothelioma Growth Trends by Regions
    • 2.2.1 Malignant Mesothelioma Market Size by Regions (2014-2025)
    • 2.2.2 Malignant Mesothelioma Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Malignant Mesothelioma Market Size by Manufacturers
    • 3.1.1 Global Malignant Mesothelioma Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Malignant Mesothelioma Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Malignant Mesothelioma Market Concentration Ratio (CR5 and HHI)
  • 3.2 Malignant Mesothelioma Key Players Head office and Area Served
  • 3.3 Key Players Malignant Mesothelioma Product/Solution/Service
  • 3.4 Date of Enter into Malignant Mesothelioma Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Malignant Mesothelioma Market Size by Type (2014-2019)
  • 4.2 Global Malignant Mesothelioma Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Malignant Mesothelioma Market Size (2014-2019)
  • 5.2 Malignant Mesothelioma Key Players in United States
  • 5.3 United States Malignant Mesothelioma Market Size by Type
  • 5.4 United States Malignant Mesothelioma Market Size by Application

6 Europe

  • 6.1 Europe Malignant Mesothelioma Market Size (2014-2019)
  • 6.2 Malignant Mesothelioma Key Players in Europe
  • 6.3 Europe Malignant Mesothelioma Market Size by Type
  • 6.4 Europe Malignant Mesothelioma Market Size by Application

7 China

  • 7.1 China Malignant Mesothelioma Market Size (2014-2019)
  • 7.2 Malignant Mesothelioma Key Players in China
  • 7.3 China Malignant Mesothelioma Market Size by Type
  • 7.4 China Malignant Mesothelioma Market Size by Application

8 Japan

  • 8.1 Japan Malignant Mesothelioma Market Size (2014-2019)
  • 8.2 Malignant Mesothelioma Key Players in Japan
  • 8.3 Japan Malignant Mesothelioma Market Size by Type
  • 8.4 Japan Malignant Mesothelioma Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Malignant Mesothelioma Market Size (2014-2019)
  • 9.2 Malignant Mesothelioma Key Players in Southeast Asia
  • 9.3 Southeast Asia Malignant Mesothelioma Market Size by Type
  • 9.4 Southeast Asia Malignant Mesothelioma Market Size by Application

10 India

  • 10.1 India Malignant Mesothelioma Market Size (2014-2019)
  • 10.2 Malignant Mesothelioma Key Players in India
  • 10.3 India Malignant Mesothelioma Market Size by Type
  • 10.4 India Malignant Mesothelioma Market Size by Application

11 Central & South America

  • 11.1 Central & South America Malignant Mesothelioma Market Size (2014-2019)
  • 11.2 Malignant Mesothelioma Key Players in Central & South America
  • 11.3 Central & South America Malignant Mesothelioma Market Size by Type
  • 11.4 Central & South America Malignant Mesothelioma Market Size by Application

12 International Players Profiles

  • 12.1 AstraZeneca
    • 12.1.1 AstraZeneca Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Malignant Mesothelioma Introduction
    • 12.1.4 AstraZeneca Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.1.5 AstraZeneca Recent Development
  • 12.2 Bristol-Myers Squibb
    • 12.2.1 Bristol-Myers Squibb Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Malignant Mesothelioma Introduction
    • 12.2.4 Bristol-Myers Squibb Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.2.5 Bristol-Myers Squibb Recent Development
  • 12.3 Roche
    • 12.3.1 Roche Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Malignant Mesothelioma Introduction
    • 12.3.4 Roche Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.3.5 Roche Recent Development
  • 12.4 Merck
    • 12.4.1 Merck Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Malignant Mesothelioma Introduction
    • 12.4.4 Merck Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.4.5 Merck Recent Development
  • 12.5 Novartis
    • 12.5.1 Novartis Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Malignant Mesothelioma Introduction
    • 12.5.4 Novartis Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.5.5 Novartis Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Malignant Mesothelioma Introduction
    • 12.6.4 Pfizer Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.6.5 Pfizer Recent Development
  • 12.7 Sanofi
    • 12.7.1 Sanofi Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Malignant Mesothelioma Introduction
    • 12.7.4 Sanofi Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.7.5 Sanofi Recent Development
  • 12.8 Eli Lilly
    • 12.8.1 Eli Lilly Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Malignant Mesothelioma Introduction
    • 12.8.4 Eli Lilly Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.8.5 Eli Lilly Recent Development
  • 12.9 Teva Pharmaceuticals
    • 12.9.1 Teva Pharmaceuticals Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Malignant Mesothelioma Introduction
    • 12.9.4 Teva Pharmaceuticals Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.9.5 Teva Pharmaceuticals Recent Development
  • 12.10 Boehringer Ingelheim GmbH
    • 12.10.1 Boehringer Ingelheim GmbH Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Malignant Mesothelioma Introduction
    • 12.10.4 Boehringer Ingelheim GmbH Revenue in Malignant Mesothelioma Business (2014-2019)
    • 12.10.5 Boehringer Ingelheim GmbH Recent Development
  • 12.11 Mylan
  • 12.12 Fresenius Kabi
  • 12.13 Sun Pharmaceuticals
  • 12.14 Corden Pharma
  • 12.15 Concordia International
  • 12.16 Kyowa Hakko Kirin
  • 12.17 Polaris Pharmaceuticals
  • 12.18 MolMed
  • 12.19 Ono Pharmaceutical
  • 12.20 Nichi-Iko Pharmaceutical

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Malignant Mesothelioma Key Market Segments
  • Table Key Players Malignant Mesothelioma Covered
  • Table Global Malignant Mesothelioma Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Malignant Mesothelioma Market Size Market Share by Type 2014-2025
  • Figure Oral Figures
  • Table Key Players of Oral
  • Figure Parenteral Figures
  • Table Key Players of Parenteral
  • Table Global Malignant Mesothelioma Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospital Pharmacies Case Studies
  • Figure Retail Pharmacies Case Studies
  • Figure Oncology Centers Case Studies
  • Figure Other Case Studies
  • Figure Malignant Mesothelioma Report Years Considered
  • Table Global Malignant Mesothelioma Market Size 2014-2025 (Million US$)
  • Figure Global Malignant Mesothelioma Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Malignant Mesothelioma Market Size by Regions 2014-2025 (Million US$)
  • Table Global Malignant Mesothelioma Market Size by Regions 2014-2019 (Million US$)
  • Table Global Malignant Mesothelioma Market Share by Regions 2014-2019
  • Figure Global Malignant Mesothelioma Market Share by Regions 2014-2019
  • Figure Global Malignant Mesothelioma Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Malignant Mesothelioma Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Malignant Mesothelioma Market Share by Manufacturers (2014-2019)
  • Figure Global Malignant Mesothelioma Market Share by Manufacturers in 2018
  • Table Global Malignant Mesothelioma Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Malignant Mesothelioma Product/Solution/Service
  • Table Date of Enter into Malignant Mesothelioma Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table Global Malignant Mesothelioma Market Size Share by Type (2014-2019)
  • Figure Global Malignant Mesothelioma Market Size Market Share by Type (2014-2019)
  • Table Global Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table Global Malignant Mesothelioma Market Size Share by Application (2014-2019)
  • Figure Global Malignant Mesothelioma Market Size Market Share by Application (2014-2019)
  • Figure Global Malignant Mesothelioma Revenue Market Share by Application in 2018
  • Figure United States Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table United States Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table United States Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table United States Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table United States Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table United States Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table United States Malignant Mesothelioma Market Share by Application (2014-2019)
  • Figure Europe Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table Europe Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table Europe Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table Europe Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table Europe Malignant Mesothelioma Market Share by Application (2014-2019)
  • Figure China Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table China Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table China Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table China Malignant Mesothelioma Market Size by Type (2014-20189) (Million US$)
  • Table China Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table China Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table China Malignant Mesothelioma Market Share by Application (2014-2019)
  • Figure Japan Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table Japan Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table Japan Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table Japan Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table Japan Malignant Mesothelioma Market Share by Application (2014-2019)
  • Figure Southeast Asia Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table Southeast Asia Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table Southeast Asia Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Malignant Mesothelioma Market Share by Application (2014-2019)
  • Figure India Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table India Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table India Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table India Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table India Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table India Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table India Malignant Mesothelioma Market Share by Application (2014-2019)
  • Figure Central & South America Malignant Mesothelioma Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Malignant Mesothelioma Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Malignant Mesothelioma Market Share (2018-2019)
  • Table Central & South America Malignant Mesothelioma Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Malignant Mesothelioma Market Share by Type (2014-2019)
  • Table Central & South America Malignant Mesothelioma Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Malignant Mesothelioma Market Share by Application (2014-2019)
  • Table AstraZeneca Company Details
  • Table AstraZeneca Revenue in Malignant Mesothelioma Business (2014-2019) (Million US$)
  • Figure AstraZeneca Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table AstraZeneca Recent Development
  • Table Bristol-Myers Squibb Company Details
  • Table Bristol-Myers Squibb Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Bristol-Myers Squibb Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Bristol-Myers Squibb Recent Development
  • Table Roche Company Details
  • Table Roche Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Roche Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Roche Recent Development
  • Table Merck Company Details
  • Table Merck Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Merck Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Merck Recent Development
  • Table Novartis Company Details
  • Table Novartis Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Novartis Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Novartis Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Pfizer Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Pfizer Recent Development
  • Table Sanofi Company Details
  • Table Sanofi Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Sanofi Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Sanofi Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Eli Lilly Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Eli Lilly Recent Development
  • Table Teva Pharmaceuticals Company Details
  • Table Teva Pharmaceuticals Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Teva Pharmaceuticals Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Teva Pharmaceuticals Recent Development
  • Table Boehringer Ingelheim GmbH Company Details
  • Table Boehringer Ingelheim GmbH Revenue in Malignant Mesothelioma Business (2014-2019)(Million US$)
  • Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Malignant Mesothelioma Business (2014-2019)
  • Table Boehringer Ingelheim GmbH Recent Development
  • Table Mylan Company Details
  • Table Fresenius Kabi Company Details
  • Table Sun Pharmaceuticals Company Details
  • Table Corden Pharma Company Details
  • Table Concordia International Company Details
  • Table Kyowa Hakko Kirin Company Details
  • Table Polaris Pharmaceuticals Company Details
  • Table MolMed Company Details
  • Table Ono Pharmaceutical Company Details
  • Table Nichi-Iko Pharmaceutical Company Details
  • Table Global Malignant Mesothelioma Market Size by Regions (Million US$) 2019-2025
  • Figure Global Malignant Mesothelioma Market Size Share by Regions (2019-2025)
  • Figure Global Malignant Mesothelioma Market Size Share by Regions in 2025
  • Figure United States Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Figure China Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Figure India Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Malignant Mesothelioma Market Size Forecast (2019-2025)(Million USD)
  • Table Global Malignant Mesothelioma Market Size by Product (2019-2025) (Million US$)
  • Figure Global Malignant Mesothelioma Market Size by Product (2019-2025)
  • Figure Global Malignant Mesothelioma Market Size by Product in 2025
  • Table Global Malignant Mesothelioma Market Size by Application (2019-2025) (Million US$)
  • Figure Global Malignant Mesothelioma Market Size by Application (2019-2025)
  • Figure Global Malignant Mesothelioma Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top